InspireMD Inc (FRA:II2)
€ 2.12 -0.08 (-3.64%) Market Cap: 58.90 Mil Enterprise Value: 16.12 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 44/100

Q3 2019 InspireMD Inc Earnings Call Transcript

Nov 12, 2019 / 01:30PM GMT
Release Date Price: €17.4 (+9.43%)
Operator

Greetings, welcome to the InspireMD Third Quarter 2019 Earnings Conference Call. (Operator Instructions) Please note this call is also being recorded.

I will now turn the conference over to your host, Mr. Glenn Garmont, Investor Relations. You may begin.

Glenn Garmont
LifeSci Advisors, LLC - MD

Thank you, Lexie. Good morning, everyone, and thank you for joining us for the InspireMD Third Quarter 2019 Business Update Conference Call.

On the line with us today is Jim Barry, Chief Executive Officer; and Craig Shore, Chief Financial Officer. We'll start with an overview of the company's results and recent highlights and then we'll open the call for your questions.

Before we begin, let me take a minute to note that this conference call may contain forward-looking statements. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. Such information is subject to known and unknown risks,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot